{"schema_version":"secwatch.filing_event.v1","accession":"0002007919-25-000063","form_type":"8-K","ticker":"INBX","cik":"0002007919","company_name":"Inhibrx Biosciences, Inc.","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.674999+00:00","generated_at":"2026-05-20T08:59:56.851469+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Inhibrx stockholders elect two Class I directors, ratify auditor at 2025 annual meeting","bullets":["Jon Faiz Kayyem, Ph.D. elected with 8,077,611 votes for, 31,060 withheld (3,384,613 broker non-votes).","Kristiina Vuori, M.D., Ph.D. elected with 6,494,317 votes for, 1,614,354 withheld (3,384,613 broker non-votes).","Ratification of BDO USA as auditor passed with 11,463,328 for, 2,918 against, 27,038 abstained.","Quorum of 11,493,284 shares (79% of eligible) was present at the May 28, 2025 virtual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0002007919-25-000063","json":"https://secwatch.observer/filing/0002007919-25-000063.json","markdown":"https://secwatch.observer/filing/0002007919-25-000063.md","text":"https://secwatch.observer/filing/0002007919-25-000063.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2007919/000200791925000063/0002007919-25-000063-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2007919/000200791925000063/inhibrx-20250528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T08:59:56.851469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}